LUPRODEX 3.75MG (LEUPROLIDE ACETATE FOR INJECTION)

Luprodex 3.75mg is a pharmaceutical-grade, long-acting Gonadotropin-Releasing Hormone (GnRH) agonist designed for the systemic clinical management of hormone-dependent conditions. Its active ingredient, Leuprolide Acetate, works by initially stimulating and then profoundly suppressing the localized production of pituitary gonadotropins. This provides a stable clinical tool for reducing systemic levels of testosterone in men and estrogen in women, clearing the path for the treatment of various localized oncological and reproductive disorders in the Nigerian medical environment.

Active Ingredient: Leuprolide Acetate 3.75mg

Drug Class: GnRH Agonist / Antineoplastic Agent

Formulation: Lyophilized Powder for Depot Suspension

Route: Intramuscular (IM) or Subcutaneous (SC) Injection

Pack Size: 1 Vial of Powder + 1 Ampoule of Solvent + Syringe/Needle

Availability: Prescription-Only Medicine (POM) — Strict specialist supervision required.

MANUFACTURER

Various Trusted Providers (e.g., Bharat Serums and Vaccines Ltd) — Specifically engineered as a microsphere depot formulation to ensure a slow, systemic release of medication over a 4-week clinical period.

WHAT IS LUPRODEX USED FOR?

Luprodex 3.75mg is primarily indicated for the palliative systemic treatment of advanced prostate cancer in men. In women, it is clinically used for the localized management of endometriosis and the systemic reduction of uterine fibroids prior to surgery. It is also a core component in Assisted Reproductive Technology (ART) to clear the path for controlled ovarian stimulation. Additionally, it is used systemically for the localized treatment of central precocious puberty in children.

IMPORTANT SAFETY INFORMATION

Tumor Flare: During the first localized week of systemic treatment, a temporary increase in hormones may occur, potentially worsening clinical symptoms (e.g., localized bone pain or urinary blockage).

Bone Density: Long-term systemic suppression of sex hormones can lead to localized bone thinning (osteoporosis). Consult your doctor about systemic calcium and Vitamin D support.

Cardiovascular Risk: Systemic androgen deprivation therapy in men may increase the localized risk of diabetes, heart attack, or sudden clinical cardiac death.

Pregnancy Contraindication: Luprodex is systemically harmful to a localized fetus. It must never be used during pregnancy; a stable clinical pregnancy test is required before starting.

HOW TO USE

This medication must be administered systemically by a healthcare professional. The localized powder must be reconstituted with the provided solvent to form a uniform systemic suspension and injected immediately. It is typically administered once every 28 to 30 days as a deep localized intramuscular or subcutaneous injection. To ensure systemic safety, rotate localized injection sites with every clinical dose. If a systemic dose is missed, it should be administered as soon as possible to maintain a stable clinical hormonal baseline.

COMMON SIDE EFFECTS

Commonly reported effects include localized hot flashes, systemic sweating, and decreased libido. Women may experience localized vaginal dryness or systemic mood swings, while men may experience localized breast tenderness (gynecomastia). Consult your doctor immediately if you experience severe localized bone pain, systemic difficulty urinating, or sudden localized weakness in the legs.

STORAGE INSTRUCTIONS

Store below 25°C in a cool, dry place away from direct sunlight. Do not freeze. In the Nigerian climate, localized heat can affect the systemic stability of the microsphere formulation; ensure the localized box remains in a temperature-controlled environment. Keep the medication in its original systemic carton to protect it from light. Keep out of reach of children.

FREQUENTLY ASKED QUESTIONS (FAQ)

Q: How long does one injection last?

A: The 3.75mg localized dose is a "one-month depot," providing systemic hormonal suppression for approximately 28 to 30 days.

Q: Will my periods stop while on Luprodex?

A: Yes. For most women, systemic treatment leads to a localized cessation of menstruation (amenorrhea), which clears the path for healing in conditions like endometriosis.

Q: Is Luprodex the same as chemotherapy?

A: No. It is a systemic hormonal therapy. While used in localized cancer treatment, it does not work by the same systemic mechanisms as traditional clinical cytotoxic chemotherapy.

Q: Is a prescription mandatory at Sanlive Pharmacy?

A: Yes. Luprodex is a high-potency systemic medication. A valid specialist's prescription (Oncologist, Gynecologist, or Urologist) is mandatory for every localized purchase.

PURCHASE NOTICE

Luprodex 3.75mg is a Prescription-Only Medicine. A valid doctor's prescription is required. Our licensed pharmacists are available to provide guidance on localized dosing intervals and systemic hormonal health monitoring.

WHY BUY FROM SANLIVE PHARMACY?

Verified Specialized Meds: We guarantee 100% original Luprodex with verified systemic purity and localized clinical potency.

Professional Handling: Our storage protocols ensure that every localized vial is protected from the Nigerian heat to maintain systemic molecular integrity.

Expert Support: Access to licensed pharmacists for guidance on managing localized side effects and systemic hormonal wellness.

Secure Delivery: Reliable and discreet shipping of essential oncology and fertility prescriptions nationwide across Nigeria.

Order Luprodex 3.75mg from Sanlive Pharmacy for hormonal support and fast delivery.